ARTICLE

A COMPREHENSIVE INSIGHTS OF THE MULTIPLE DOSE REGIMEN

  1. HOME
  2. ARTICLE

04 Pages : 34-40

http://dx.doi.org/10.31703/gdddr.2019(IV-I).04      10.31703/gdddr.2019(IV-I).04      Published : Dec 2019

A Comprehensive Insights of the Multiple Dose Regimen

Abstract

    A multiple dose regimen is a concept that is used for certain diseases as arthritis, heart diseases etc. It is used to increase the therapeutic activity and clinical efficacy of the drugs. Drugs are usually used in single doses to produce acute effect but in cases where chronic affect is required multiple dosage regimen is required. Designing the dosage regimen and maintaining the drug concentration in blood plasma after administration are the primary goals to achieve safety and efficacy. That is to maintain drug concentration in therapeutic window. Moreover, the IV infusion and continuous IV diffusion is reviewed.

    Multiple Dose Regimen, Loading Dose, Drug Accumulation, IV Infusion, Pharmacokinetics

    (1) Ayesha Ayub
    Undergraduate Students (Final year), Department of Pharmacy, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan.
    (2) Abid ul Haq
    Undergraduate Students (Final year), Department of Pharmacy, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan.
    (3) Mubashar Rehman
    Assistant Professor, Department of Pharmacy, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan.
Fulltext PDF

References

  • Agashe, H., Sahoo, K., Lagisetty, P., & Awasthi, V. (2011). Cyclodextrin-mediated entrapment of curcuminoid 4-[3, 5-bis (2-chlorobenzylidene- 4-oxo-piperidine-1-yl)-4-oxo-2-butenoic acid] or CLEFMA in liposomes for treatment of xenograft lung tumor in rats. Colloids and Surfaces B: Biointerfaces, 84(2), 329-337.
  • Allen, T. M. (2002). Ligand-targeted therapeutics in anticancer therapy. Nature Reviews Cancer, 2(10), 750.
  • Anselmo, A. C., & Mitragotri, S. (2014). Cell- mediated delivery of nanoparticles: taking advantage of circulatory cells to target nanoparticles. Journal of controlled release, 190, 531-541.
  • Attama, A., Reichl, S., & Müller-Goymann, C. (2009). Sustained release and permeation of timolol from surface-modified solid lipid nanoparticles through bioengineered human cornea. Current eye research, 34(8), 698-705.
  • Bhagwat, R., & Vaidhya, I. (2013). Novel drug delivery systems: An overview. International Journal of Pharmaceutical Sciences and Research, 4(3), 970.
  • Booysen, L., Kalombo, L., Brooks, E., Hansen, R., Gilliland, J., Gruppo, V., . . . Kotze, A. (2013). In vivo/in vitro pharmacokinetic and pharmacodynamic study of spray-dried poly- (dl-lactic-co-glycolic) acid nanoparticles encapsulating rifampicin and isoniazid. International journal of pharmaceutics, 444(1- 2), 10-17.
  • Dalpiaz, A., Vighi, E., Pavan, B., & Leo, E. (2009). Fabrication via a nonaqueous nanoprecipitation method, characterization and in vitro biological behavior of N6-cyclopentyladenosine-loaded nanoparticles. Journal of pharmaceutical sciences, 98(11), 4272-4284.
  • Danhier, F., Ansorena, E., Silva, J. M., Coco, R., Le Breton, A., & Préat, V. (2012). PLGA-based nanoparticles: an overview of biomedical applications. Journal of controlled release, 161(2), 505-522.
  • Douglas, K. L., & Tabrizian, M. (2005). Effect of experimental parameters on the formation of alginate-chitosan nanoparticles and evaluation of their potential application as DNA carrier. Journal of Biomaterials Science, Polymer Edition, 16(1), 43-56.
  • El-Nour, K. M. A., Eftaiha, A. a., Al-Warthan, A., & Ammar, R. A. (2010). Synthesis and applications of silver nanoparticles. Arabian journal of chemistry, 3(3), 135-140.
  • Emeje, M. O., Obidike, I. C., Akpabio, E. I., & Ofoefule, S. I. (2012). Nanotechnology in drug delivery. Recent advances in novel drug carrier systems, 69-106.
  • Galindo-Rodriguez, S., Allemann, E., Fessi, H., & Doelker, E. (2004). Physicochemical parameters associated with nanoparticle formation in the salting-out, emulsification- diffusion, and nanoprecipitation methods. Pharmaceutical research, 21(8), 1428-1439.
  • Ganachaud, F., & Katz, J. L. (2005). Nanoparticles and nanocapsules created using the Ouzo effect: spontaneous emulsification as an alternative to ultrasonic and high-shear devices. ChemPhysChem, 6(2), 209-216.
  • Gao, Y., Chen, L., Zhang, Z., Chen, Y., & Li, Y. (2011). Reversal of multidrug resistance by reduction-sensitive linear cationic click polymer/iMDR1-pDNA complex nanoparticles. Biomaterials, 32(6), 1738-1747.
  • Geçer, A., Yıldız, N., Çalımlı, A., & Turan, B. (2010). Trimethyl chitosan nanoparticles enhances dissolution of the poorly water soluble drug Candesartan-Cilexetil. Macromolecular research, 18(10), 986-991.
  • Greish, K. (2010). Enhanced permeability and retention (EPR) effect for anticancer nanomedicine drug targeting Cancer Nanotechnology (pp. 25-37): Springer
  • Hans, M. L., & Lowman, A. M. (2002). Biodegradable nanoparticles for drug delivery and targeting. Current Opinion in Solid State and Materials Science, 6(4), 319-327.
  • In, G. K., & Nieva, J. (2015). Emerging chemotherapy agents in lung cancer: nanoparticles therapeutics for non-small cell lung cancer. Translational Cancer Research, 4(4), 340-355.
  • skandar, F., Gradon, L., & Okuyama, K. (2003). Control of the morphology of nanostructured particles prepared by the spray drying of a nanoparticle sol. Journal of Colloid and Interface Science, 265(2), 296-303.
  • Jain, S., Mittal, A., & K Jain, A. (2011). Enhanced topical delivery of cyclosporin-A using PLGA nanoparticles as carrier. Current nanoscience, 7(4), 524-530.
  • Jain, S., Mittal, A., K Jain, A., R Mahajan, R., & Singh, D. (2010). Cyclosporin A loaded PLGA nanoparticle: preparation, optimization, in-vitro characterization and stability studies. Current Nanoscience, 6(4), 422-431.
  • Khan, I., Saeed, K., & Khan, I. (2017). Nanoparticles: Properties, applications and toxicities. Arabian journal of chemistry.
  • Kim, B., Hwang, S., Park, J., & Park, H. J. (2002). Preparation and characterization of drug- loaded polymethacrylate microspheres by an emulsion solvent evaporation method. Journal of microencapsulation, 19(6), 811-822.
  • Kostag, M., Köhler, S., Liebert, T., & Heinze, T. (2010). Pure cellulose nanoparticles from trimethylsilyl cellulose. Paper presented at the Macromolecular symposia.
  • Kozek, K. A., Kozek, K. M., Wu, W.-C., Mishra, S. R., & Tracy, J. B. (2013). Large-scale synthesis of gold nanorods through continuous secondary growth. Chemistry of Materials, 25(22), 4537- 4544.
  • Kreyling, W. G., Semmler, M., & Möller, W. (2004). Dosimetry and toxicology of ultrafine particles. Journal of Aerosol Medicine, 17(2), 140-152
  • Kumar, P., Sulochana, P., Nirmala, G., Haridattatreya, M., & Satchidanandam, V. (2004). Conserved amino acids 193-324 of non-structural protein 3 are a dominant source of peptide determinants for CD4 and CD8 T cells in a healthy Japanese encephalitis virus- endemic cohort. Journal of General Virology, 85(5), 1131-1143.
  • Lamprecht, B., Schider, G., Lechner, R., Ditlbacher, H., Krenn, J. R., Leitner, A., & Aussenegg, F. R. (2000). Metal nanoparticle gratings: influence of dipolar particle interaction on the plasmon resonance. Physical review letters, 84(20), 4721.
  • Laurent, S., Forge, D., Port, M., Roch, A., Robic, C., Vander Elst, L., & Muller, R. N. (2008). Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chemical reviews, 108(6), 2064-2110.
  • Liu, P. (2013). Modification strategies for carbon nanotubes as a drug delivery system. Industrial & Engineering Chemistry Research, 52(38), 13517-13527.
  • Liu, Z., Wu, Y., Guo, Z., Liu, Y., Shen, Y., Zhou, P., & Lu, X. (2014). Effects of internalized gold nanoparticles with respect to cytotoxicity and invasion activity in lung cancer cells. PLoS One, 9(6), e99175.
  • Lu, Z., Bei, J., & Wang, S. (1999). A method for the preparation of polymeric nanocapsules without stabilizer. Journal of Controlled Release, 61(1-2), 107-112.
  • Marelli, U. K., Rechenmacher, F., Sobahi, T. R. A., Mas-Moruno, C., & Kessler, H. (2013). Tumor targeting via integrin ligands. Frontiers in oncology, 3, 222.
  • Mishra, B., Patel, B. B., & Tiwari, S. (2010). Colloidal nanocarriers: a review on formulation technology, types and applications toward targeted drug delivery. Nanomedicine: Nanotechnology, biology and medicine, 6(1), 9- 24.
  • Mohanraj, V., & Chen, Y. (2006). Nanoparticles-a review. Tropical journal of pharmaceutical research, 5(1), 561-573.
  • Morones, J. R., Elechiguerra, J. L., Camacho, A., Holt, K., Kouri, J. B., Ramírez, J. T., & Yacaman, M. J. (2005). The bactericidal effect of silver nanoparticles. Nanotechnology, 16(10), 2346.
  • Mu, L., & Feng, S. (2003). A novel controlled release formulation for the anticancer drug paclitaxel (Taxol®): PLGA nanoparticles containing vitamin E TPGS. Journal of controlled release, 86(1), 33-48.
  • Muhamad12, I. I., Selvakumaran, S., & Lazim, N. A. M. (2014). Designing polymeric nanoparticles for targeted drug delivery system. Nanomed, 287, 287.
  • Nel, A., Xia, T., Mädler, L., & Li, N. (2006). Toxic potential of materials at the nanolevel. science, 311(5761), 622-627.
  • Nicoli, S., Santi, P., Couvreur, P., Couarraze, G., Colombo, P., & Fattal, E. (2001). Design of triptorelin loaded nanospheres for transdermal iontophoretic administration. International journal of pharmaceutics, 214(1-2), 31-35
  • Ochekpe, N. A., Olorunfemi, P. O., & Ngwuluka, N. C. (2009). Nanotechnology and drug delivery part 2: nanostructures for drug delivery. Tropical journal of pharmaceutical research, 8(3).
  • Ouyang, Y., Shi, H., Fu, R., & Wu, D. (2013). Highly monodisperse microporous polymeric and carbonaceous nanospheres with multifunctional properties. Scientific reports, 3, 1430.
  • Pandey, N., Dhiman, S., Srivastava, T., & Majumder, S. (2016). Transition metal oxide nanoparticles are effective in inhibiting lung cancer cell survival in the hypoxic tumor microenvironment. Chemico-biological interactions, 254, 221-230.
  • Poland, C. A., Duffin, R., Kinloch, I., Maynard, A., Wallace, W. A., Seaton, A., . . . Donaldson, K. (2008). Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nature nanotechnology, 3(7), 423.
  • Rangari, A. T., & Ravikumar, P. (2015). Polymeric nanoparticles based topical drug delivery: an overview. Asian Journal of Biomedical and Pharmaceutical Sciences, 5(47), 5.
  • Rodrigues, S., da Costa, A. M. R., & Grenha, A. (2012). Chitosan/carrageenan nanoparticles: Effect of cross-linking with tripolyphosphate and charge ratios. Carbohydrate polymers, 89(1), 282-289.
  • Soppimath, K. S., Aminabhavi, T. M., Kulkarni, A. R., & Rudzinski, W. E. (2001). Biodegradable polymeric nanoparticles as drug delivery devices. Journal of controlled release, 70(1-2), 1-20.
  • Stevanovic, M., & Uskokovic, D. (2009). Poly (lactide-co-glycolide)-based micro and nanoparticles for the controlled drug delivery of vitamins. Current nanoscience, 5(1), 1-14
  • Venkatesh, D. N., Baskaran, M., Karri, V. V. S. R., Mannemala, S. S., Radhakrishna, K., & Goti, S. (2015). Fabrication and in vivo evaluation of Nelfinavir loaded PLGA nanoparticles for enhancing oral bioavailability and therapeutic effect. Saudi Pharmaceutical Journal, 23(6), 667-674.
  • Wang, Y., Wei, X., Zhang, C., Zhang, F., & Liang, W. (2010). Nanoparticle delivery strategies to target doxorubicin to tumor cells and reduce side effects. Therapeutic delivery, 1(2), 273- 287.
  • Xu, Y., Roy, R., Cassaro, G., & Ramsden, J. (2009). Development of a cost estimating framework for nanotechnology based products Global Perspective for Competitive Enterprise, Economy and Ecology (pp. 193-201): Springer.
  • Yang, W.-W., & Pierstorff, E. (2012). Reservoir- based polymer drug delivery systems. Journal of laboratory automation, 17(1), 50-58.

Cite this article

APA

CHICAGO

    CHICAGO : Ayub, Ayesha, Abid ul Haq, and Mubashar Rehman. 2019. "A Comprehensive Insights of the Multiple Dose Regimen." Global Drug Design & Development Review, IV (I): 34-40 doi: 10.31703/gdddr.2019(IV-I).04

HARVARD

    HARVARD : AYUB, A., HAQ, A. U. & REHMAN, M. 2019. A Comprehensive Insights of the Multiple Dose Regimen. Global Drug Design & Development Review, IV, 34-40.

MHRA

    MHRA : Ayub, Ayesha, Abid ul Haq, and Mubashar Rehman. 2019. "A Comprehensive Insights of the Multiple Dose Regimen." Global Drug Design & Development Review, IV: 34-40

MLA

    MLA : Ayub, Ayesha, Abid ul Haq, and Mubashar Rehman. "A Comprehensive Insights of the Multiple Dose Regimen." Global Drug Design & Development Review, IV.I (2019): 34-40 Print.

OXFORD

    OXFORD : Ayub, Ayesha, Haq, Abid ul, and Rehman, Mubashar (2019), "A Comprehensive Insights of the Multiple Dose Regimen", Global Drug Design & Development Review, IV (I), 34-40

TURABIAN

    TURABIAN : Ayub, Ayesha, Abid ul Haq, and Mubashar Rehman. "A Comprehensive Insights of the Multiple Dose Regimen." Global Drug Design & Development Review IV, no. I (2019): 34-40. https://doi.org/10.31703/gdddr.2019(IV-I).04